최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.19 no.8 = no.112, 2009년, pp.1073 - 1080
김초희 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소) , 김민영 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소) , 이수연 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소) , 문지영 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소) , 한송이 (조선대학교 의과대학 내성세포연구센터) , 박혜경 (한국나노바이오테크놀러지센터) , 강호성 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소)
A number of studies have demonstrated that the regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the risks of colorectal, oesophageal and lung cancers. NSAIDs have been shown to exert their anti-cancer effects through inducing apoptosis in cancer cells. The susceptibility of tu...
Adhami, V. M., A. Malik, N. Zaman, S. Sarfaraz, I. A. Siddiqui, D. N. Syed, F. Afaq, F. S. Pasha, M. Saleem, and H. Mukhtar. 2007. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin. Cancer Res. 13, 1611-1619
Baek, S. J., K. Kim, J. B. Nixon, L. C. Wilson, and T. E. Eling. 2001. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol. 59, 901-908
Baek, S. J., R. Okazaki, S. H. Lee, J. Martinez, J. S. Kim, K. Yamaguchi, Y. Mishina, D. W. Martin, A. Shoieb, M. F. McEntee, and T. E. Eling. 2006. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131, 1553-1560
Baek, S. J., L. Wilson, and T. E. Eling. 2002. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23, 425-434
Banu, N., A. Buda, S. Chell, D. Elder, M. Moorghen, C. Paraskeva, D. Qualtrough, and M. Pignatelli. 2007. Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor
Brognard, J., A. S. Clark, Y. Ni, and P. A. Dennis. 2001. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 61, 3986-3997
Brognard, J. and P. A. Dennis. 2002. Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. Cell Death Differ. 9, 893-904
Chen, Y. L., P. C. Lin, S. P. Chen, C. C. Lin, N. M. Tsai, Y. L. Cheng, W. L. Chang, S. Z. Lin, and H. J. Harn. 2007. Activation of Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1 via Extracellular Signal-Regulated
Clark, A. S., K. West, S. Streicher, and P. A. Dennis. 2002. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther. 1, 707-717
Crowell, J. A. and V. E. Steele. 2003. AKT and the phosphatidylinositol 3-kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment. J. Natl. Cancer Inst. 95, 291-302
Crowell, J. A., V. E. Steele, and J. R. Fay. 2007. Targeting the AKT protein kinase for cancer chemoprevention. Mol. Cancer Ther. 6, 2139-2948
Danial, N. N. and S. J. Korsmeyer. 2004. Cell death: Critical control points. Cell 116, 205-219
Dixon, R. A. and D. Ferreira. 2003. Genistein. Phytochemistry 60, 205-211
Garg, A. K., T. A. Buchholz, and B. B. Aggarwal. 2005. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal. 7, 1630-1647
Hawk, E. T. and B. Levin. 2005. Colorectal cancer prevention. J. Clin. Oncol. 23, 378-391
Hu, H., C. Jiang, G. Li, and J. Lu. 2005. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. Carcinogenesis 269, 1374-1381
Huang, C., J. Li, M. Ding, S. S. Leonard, L. Wang, V. Castranova, V. Vallyathan, and X. Shi. 2001. UV Induces phosphorylation of protein kinase B (Akt) at Ser-473 and Thr-308 in mouse epidermal Cl 41 cells through hydrogen peroxide. J. Biol. Chem. 276, 40234-40240
Huang, Y., Q. He, M. J. Hillman, R. Rong, and M. S. Sheikh. 2001. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Res. 61, 6918-6924
Hung, W. C., H. C. Chang, M. R. Pan, T. H. Lee, and L. Y. Chuang. 2000. Induction of p27KIP1 as a Mechanism Underlying NS398- Induced Growth Inhibition in Human Lung Cancer Cells. Mol. Pharmacol. 58, 1398-1403
Kim, C. H., S. I. Han, S. Y. Lee, H. S. Youk, J. Y. Moon, H. Q. Duong, M. J. Park, Y. M. Joo, H. G. Park, Y. J. Kim, M. A. Yoo, S. C. Lim, and H. S. Kang. 2007. Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells. J. Cell Phyiol. 211, 371-385
Li, M., X. Wu, and X. C. Xu. 2001. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin. Cancer Res. 7, 1010-1016
Liou, J. Y., D. Ghelani, S. Yeh, and K. K. Wu. 2007. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon. Cancer Res. 67, 3185-3191
Liu, X. H., S. Yao, A. Kirschenbaum, and A. C. Levine. 1998. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res. 58, 4245-4249
Lowe, S. W. and A. W. Lin. 2000. Apoptosis in cancer. Carcinogenesis 21, 485-495
MacKeigan, J. P., D. Taxman, D. Hunter, H. S. Earp 3rd, L. M. Graves, and J. P. Ting. 2002. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. Clin. Cancer Res. 8, 2091-2099
Meeran, S. M. and S. K. Katiyar. 2008. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front. Biosci. 13, 2191-2202
Meier, F., S. Busch, K. Lasithiotakis, D. Kulms, C. Garbe, E. Maczey, M. Herlyn, and B. Schittek. 2007. Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br. J. Dermatol. 156,
Minter, H. A., J. W. Eveson, S. Huntley, D. J. Elder, and A. Hague. 2003. The Cyclooxygenase 2-selective Inhibitor NS398 Inhibits Proliferation of Oral Carcinoma Cell Lines by Mechanisms Dependent and Independent of Reduced Prostaglandin E2 Synthesis. Clin. Cancer Res. 9, 1885-1897
Newman, D., M. Sakaue, J. S. Koo, K. S. Kim, S. J. Baek, T. E. Eling, and A. M. Jetten. 2003. Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma
Saha, D., H. Pyo, and H. Choy. 2003. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer. Am. J. Clin. Oncol. 26, S70-74
Tegeder, I., J. Pfeilschifter, and G. Geisslinger. 2001. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15, 2057-2072
Totzke, G., K. Schulze-Osthoff, and R. U. Janicke. 2003. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene 22, 8021-8030
Ulrich, C. M., J. Bigler, and J. D. Potter. 2006. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat. Rev. Cancer 6, 130-140
Vane, J. R. and R. M. Botting. 1998. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am. J. Med. 104, 2S-8S
Wilson, L. C., S. J. Baek, A. Call, and T. E. Eling. 2003. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer 105, 747-753
Yamaguchi, H. and H. G. Wang. 2001. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 53, 7779-7786
Yamaguchi, K., S. H. Lee, T. E. Eling, and S. J. Baek. 2004. Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of posphatidylinositol 3-knase/AKT/GSK-3 Pathway. J. Biol. Chem. 279, 49617-49623
Yeh, T. C., P. C. Chiang, T. K. Li, J. L. Hsu, C. J. Lin, S. W. Wang, C. Y. Peng, and J. H. Guh. 2007. Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochm. Pharmacol. 73, 782-792
Zhang, L., J. Yu, B. H. Park, K. W. Kinzler, and B. Vogelstein. 2000. Role of BAX in the apoptotic response to anticancer agents. Science 290, 989-992
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.